Ting-Yu Lu

Ting-Yu Lu

Auto-generated profile, based on publicly available information

Ting-Yu Lu

Program in Materials Science and Engineering University of California San Diego La Jolla California USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2018 in Journal of Applied Physics
Verified
Journal Article
Open access
TLTingyu Lu
Tingyu Lu
KKKyunghoon Kim
Kyunghoon Kim
XLXiaobo Li
Xiaobo Li
JZJun Zhou
Jun Zhou
GCGang Chen
Gang Chen
JLJun Liu
Jun Liu
Recent research has highlighted the potential to achieve high-thermal-conductivity polymers by aligning their molecular chains. Combined with other merits, such as low-cost, corrosion resistance, and light weight, such polymers are attractive for heat transfer applications. Due to their quasi-one-dimensional structural nature, the understanding on the thermal transport in those ultra-drawn semicrystalline polymer fibers or films is still lacking. In this paper, we built the ideal repeating units of semicrystalline polyethylene and studied their dependence of thermal conductivity on different crystallinity and interlamellar topology using the molecular dynamics simulations. We found that the conventional models, such as the Choy-Young's model, the series model, and Takayanagi's model, cannot accurately predict the thermal conductivity of the quasi-one-dimensional semicrystalline polyethylene. A modified Takayanagi's model was proposed to explain the dependence of thermal conductivity on the bridge number at intermediate and high crystallinity. We also analyzed the heat transfer pathways and demonstrated the substantial role of interlamellar bridges in the thermal transport in the semicrystalline polyethylene. Our work could contribute to the understanding of the structure–property relationship in semicrystalline polymers and shed some light on the development of plastic heat sinks and thermal management in flexible electronics.

1 October 2020 in Biomaterials
Verified
Journal Article
Closed access
TLTe-I Liu
Te-I Liu
TLTing-Yu Lu
Ting-Yu Lu
YYYing-Chieh Yang
Ying-Chieh Yang
SCSiou-Han Chang
Siou-Han Chang
HCHsin-Hung Chen
Hsin-Hung Chen
CCChi-Shiun Chiang
Chi-Shiun Chiang

1 November 2019 in AIP Advances
Verified
Journal Article
Open access
PDF file
HSHarish Subramanyan
Harish Subramanyan
KKKyunghoon Kim
Kyunghoon Kim
TLTingyu Lu
Tingyu Lu
JZJun Zhou
Jun Zhou
JLJun Liu
Jun Liu
Several models have been employed in the past to estimate interfacial thermal conductance (ITC) for different material interfaces, of which the diffuse mismatch model (DMM) has been generally accepted as reliable for rough material interfaces at high temperature. Even though the DMM has been shown to predict the correct order of magnitude in isotropic material interfaces, it is unable to reproduce the same accuracy for low-dimensional anisotropic layered materials, which have many potential applications. Furthermore, the use of approximated dispersion curves tends to overestimate the ITC. In this work, we propose a new method that utilizes a mode-to-mode comparison within the DMM framework to predict ITC. We employed this model to calculate ITC between layered materials such as MoS2 and graphite and metals such as Al, Au, and Cr. We then compared our values with previous literature data that employ linear dispersion relations and experimental data from time-domain thermoreflectance measurements. This new framework was then used to visualize the phonon focusing effect in anisotropic materials. Further analysis revealed that counting only the three acoustic modes and neglecting the low-frequency optical modes lead to significant underestimation of the ITC using DMM. Our findings indicate that it is imperative to use the exact full phonon dispersion relations in evaluating the ITC for low-dimensional layered materials.

12 March 2025 in Biomaterials
Verified
Journal Article
Closed access
TLTing-Yu Lu
Ting-Yu Lu
YJYichun Ji
Yichun Ji
CLCheng Lyu
Cheng Lyu
ESErin Nicole Shen
Erin Nicole Shen
YSYazhi Sun
Yazhi Sun
SCShaochen Chen
Shaochen Chen

8 November 2024 in Materials Today Bio
Verified
Journal Article
Open access
EQEdgar Daniel Quiñones
Edgar Daniel Quiñones
MWMu-Hui Wang
Mu-Hui Wang
KLKuan-Ting Liu
Kuan-Ting Liu
TLTing-Yu Lu
Ting-Yu Lu
GLGuan-Yu Lan
Guan-Yu Lan
NCNaichen Cheng
Naichen Cheng
The management of diabetic wounds presents a considerable challenge within the realm of clinical practice. Cellular-derived nanoparticles, or extracellular vesicles (EV), generated by human adipose-derived stem cells (hASCs) have been investigated as promising candidates for the treatment of diabetic wounds. Nevertheless, limitations on the yield, as well as the qualitative angiogenic properties of the EV produced, have been a persistent issue. In this study, a novel approach involving the use of various cell culture morphologies, such as cell spheroids, on hASC was used to promote both EV yield and qualitative angiogenic properties for clinical use, with an emphasis on the in vivo angiogenic properties exhibited by the EV. Moreover, an increase in the secretion of the EV was confirmed after cell spheroid culture. Furthermore, microRNA(miRNA) analysis of the produced EVs indicated an increase in the presence of wound healing-associated miRNAs on the cell spheroid EV. Analysis of the effectiveness of the treated EVs in vitro indicated a significant promotion of the biological function of fibroblast and endothelial cells, cell migration, and cell proliferation post-cell spheroid EV application. Meanwhile, in vivo experiments on diabetic rats indicated a significant increase in collagen production, re-epithelization, and angiogenesis of the diabetic wound after EV administration. In this investigation, we posit that the use of cell spheroids for the culture of hASC represents a novel approach to enhance the substantial secretion of extracellular vesicles while increasing the angiogenic wound healing properties. This innovation holds promise for augmenting the therapeutic potential of EVs in diabetic wound healing, aligning with the exigencies of clinical applications for these nanoparticles.

20 April 2026 in Advanced Functional Materials
Verified
Journal Article
Open access
PDF file
TLTing‐Yu Lu
Ting‐Yu Lu
CLCheng Lyu
Cheng Lyu
ESErin N. Shen
Erin N. Shen
EBEmma L. Berman
Emma L. Berman
YSYazhi Sun
Yazhi Sun
SCShaochen Chen
Shaochen Chen
Developing predictive human in vitro drug screening platforms requires models that capture the spatial complexity, cellular diversity, and functional maturity of a native liver tissue. Here, we present a bioprinted multi‐cellular liver model that integrates induced pluripotent stem cells (iPSCs)‐derived hepatocytes and endothelial cells within a matrix metalloproteinase (MMP)‐degradable, YIGSR‐functionalized polyethylene glycol (PEG)—norbornene (NB) hydrogel. The multi‐cellular architecture recapitulates hepatic organization by spatially positioning endothelial and parenchymal compartments in physiologically relevant arrangements, enabling paracrine signaling, enhanced nutrient exchange, and stable cell–cell/matrix interactions. Integrated with a dynamic microfluidic perfusion system, the construct supports matrix remodeling, delivers physiological shear stress, and sustains a well‐oxygenated microenvironment. Compared to static culture, dynamic perfusion preserved long‐term albumin and urea secretion, enhanced cytochrome P450 activity, reduced oxidative stress, and maintained mitochondrial integrity over extended culture periods. Transcriptomic profiling confirmed significant enrichment of metabolic, junctional, and drug‐processing pathways. Functionally, the multi‐cellular platform demonstrated robust and inducible drug‐metabolizing capacity, enabling accurate identification of clinically relevant hepatotoxic compounds. Drug potency metrics—including IC 50 and benchmark dose values—closely matched reported human plasma concentration thresholds, underscoring the translational potential of the system. This reproducible, physiomimetic multi‐cellular liver platform provides a high‐content, human‐iPSC based liver tissue to conventional preclinical models, bridging the gap between early‐stage drug testing and clinical outcomes while offering new opportunities for predictive pharmacology and toxicity assessment.